← Eichor
Study identifier: NCT00500123 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study

Condition: Alpha-1 Antitrypsin Deficiency  ·  Sponsor: University of Florida

PhaseN/A
Planned participants50000
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersYes

About this study

The Alpha-1 Coded Testing (ACT) Study was established to study genetic testing and outcomes of individuals at risk for alpha-1 antitrypsin deficiency.

This description comes directly from the study's public registry record.

Talk to the study team

Michelle Owens, RN, BSN  ·  352-273-6339  ·  Sandra.Owens@medicine.ufl.edu

Allison Faunce, B.A.  ·  352-273-8666  ·  Allison.Faunce@medicine.ufl.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of FloridaGainesville, Florida, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT00500123